Thalidomide Export Market Intelligence: India's 153 Suppliers Shipping to 92 Countries — TransData Nexus 2026

Q: Who are the top thalidomide exporters from India?

The top thalidomide exporters from India are: 1. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — $468.6K (24.2% market share); 2. UNITED BIOTECH PRIVATE LIMITED — $307.7K (15.9% market share); 3. JODAS EXPOIM PRIVATE LIMITED — $257.8K (13.3% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $142.5K (7.4% market share); 5. KANCHAN SAGAR PHARMACEUTICALS — $98.7K (5.1% market share). Together they account for 65.9% of India's total thalidomide export value.

Q: What is the total export value of thalidomide from India?

The total export value of thalidomide from India is $1.9M USD, recorded across 822 shipment transactions from 153 active exporters to 92 destination countries. The average shipment value is $2.4K.

Q: Which countries import thalidomide from India?

India exports thalidomide to 92 countries worldwide. The top importing countries are: ALGERIA (26.8% share, $518.2K), SRI LANKA (14.5% share, $280.1K), SERBIA (13.8% share, $266.4K), VIETNAM (11.6% share, $223.5K), SENEGAL (4.1% share, $79.2K). These five markets account for 70.7% of total export value.

Q: What is the HS code for thalidomide exports from India?

The primary HS code for thalidomide exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of thalidomide exports from India?

The average unit price for thalidomide exports from India is $8.66 USD per unit, with prices ranging from $0.10 to $206.67 depending on formulation, packaging, and order volume. The total market is valued at $1.9M across 822 shipments.

Q: Which ports handle thalidomide exports from India?

The primary ports for thalidomide exports from India are SAHAR AIR CARGO ACC (INBOM4) (26.2% of shipments), SAHAR AIR (22.9% of shipments), Bombay Air (10.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (7.9% of shipments), DELHI AIR (7.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of thalidomide?

India is one of the world's leading exporters of thalidomide due to its large base of 153 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports thalidomide to 92 countries, demonstrating 47% global market coverage.

Q: What certifications do Indian thalidomide exporters need?

Indian thalidomide exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import thalidomide from India?

There are 256 registered buyers importing thalidomide from India, spread across 92 countries. The repeat buyer rate is 52.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top thalidomide supplier from India?

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the leading thalidomide exporter from India with a market share of 24.2% and total export value of $468.6K across 23 shipments. The top 5 suppliers together control 65.9% of total export value.

Suresh Sormare

Thalidomide

India Pharmaceutical Trade Intelligence

$1.9M153 Suppliers92 CountriesHS 30049049

ExportsIndia → ALGERIA26.8%India → SRI LANKA14.5%

ImportsUNITED KINGDOM → India$105

#1 Supplier: BDR PHARMACEUTICALS #1 Buyer: SOFTCARE INTERNATIONAL(PVT)LTD

Thalidomide Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Thalidomide to the World

Between 2022 and 2026, India exported $1.9M worth of thalidomide across 822 verified shipments to 92 countries — covering 47% of world markets in the Advanced Oncology segment. The largest destination is ALGERIA (26.8%). BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED leads with a 24.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Thalidomide export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Thalidomide export data snapshot — $1.9M · 153 exporters · 92 countriesTransData Nexus · Indian Customs Data

Top Thalidomide Exporters from India

153 active exporters · Ranked by export value

View all 153 →

Top Thalidomide Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	$468.6K	23	2	24.2%
2	UNITED BIOTECH PRIVATE LIMITED

Top Countries Importing Thalidomide from India

92 destination markets · Ranked by import value

All 92 countries →

Top Countries Importing Thalidomide from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	ALGERIA	$518.2K	26.8%
2	SRI LANKA	$280.1K	14.5%
3	SERBIA	$266.4K	13.8%
4	VIETNAM	$223.5K	11.6%
5	SENEGAL	$79.2K	4.1%
6	POLAND	$49.2K	2.5%
7	SINGAPORE	$40.8K	2.1%
8	EL SALVADOR	$30.7K	1.6%
9	TURKEY	$29.2K	1.5%
10	IRAQ	$27.0K	1.4%

ALGERIA is India's largest thalidomide export destination, absorbing 26.8% of total exports worth $518.2K. The top 5 importing countries — ALGERIA, SRI LANKA, SERBIA, VIETNAM, SENEGAL — together account for 70.7% of India's total thalidomide export value. The remaining 87 destination countries collectively receive the other 29.3%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Thalidomide to India?

1 origin countries · Total import value: $105

India imports thalidomide from 1 countries with a combined import value of $105. The largest supplier is UNITED KINGDOM ($105, 1 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Thalidomide to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED KINGDOM	$105	1	100.0%

UNITED KINGDOM is the largest supplier of thalidomide to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Thalidomide

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, thalidomide is approved for the treatment of multiple myeloma and erythema nodosum leprosum. The FDA's Orange Book lists several approved Abbreviated New Drug Applications (ANDAs) for thalidomide, indicating the presence of generic competition. The regulatory pathway for thalidomide involves stringent risk evaluation and mitigation strategies (REMS) due to its teratogenic effects. Given the presence of 153 active Indian exporters, compliance with FDA regulations, including REMS, is crucial for market entry and sustained presence in the U.S. market.

2EU & UK Regulatory Framework

The European Medicines Agency (EMA) granted orphan designation to thalidomide for the treatment of multiple myeloma in September 2001, leading to its authorization in the EU in April 2008. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA guidelines, requiring adherence to Good Manufacturing Practice (GMP) standards. Indian exporters must ensure compliance with these regulations to access the European and UK markets.

3WHO Essential Medicines & Global Standards

Thalidomide is included in the WHO Model List of Essential Medicines, reflecting its importance in treating specific conditions. (who.int) It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different markets.

4India Regulatory Classification

In India, thalidomide is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for its dispensation. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for thalidomide, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with international regulations.

5Patent & Exclusivity Status

The primary patents for thalidomide have expired, leading to increased generic competition. This competitive landscape necessitates Indian exporters to focus on quality assurance and regulatory compliance to maintain market share.

6Recent Industry Developments

In May 2025, the WHO updated its Model List of Essential Medicines, reaffirming thalidomide's inclusion, which underscores its continued global therapeutic relevance. (who.int) In January 2026, the FDA issued new guidance on REMS requirements for thalidomide, emphasizing the need for exporters to stay abreast of evolving regulatory frameworks. Additionally, in March 2026, the EMA revised its GMP guidelines, impacting manufacturing practices for thalidomide and necessitating compliance from Indian exporters targeting the EU market.

These developments highlight the dynamic regulatory environment surrounding thalidomide, necessitating continuous monitoring and adaptation by Indian exporters to ensure compliance and market competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Thalidomide

Retail & reference prices across 9 markets vs. India FOB export price of $8.66/unit

Global Price Benchmark for Thalidomide across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$X	USD	According to the FDA Orange Book, Thalidomide is approved for use in the United States.
United Kingdom	$X	GBP	As per the NHS Drug Tariff, Thalidomide is listed for use within the National Health Service.
Germany	$X	EUR	The European Medicines Agency (EMA) has authorized the use of Thalidomide in Germany.
Australia	$X	AUD

Supply Chain Risk Assessment — Thalidomide

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 70% of KSMs and APIs are imported from China, making the supply chain vulnerable to disruptions. This dependency is particularly concerning for drugs like thalidomide, where specific KSMs are essential for synthesis. Any interruption in the supply of these materials can halt production, leading to shortages and increased costs.

Recent geopolitical tensions and trade restrictions have exacerbated these vulnerabilities. For instance, in October 2025, China's implementation of export controls prioritized domestic supply, reducing the availability of critical KSMs for international markets. Such measures have led to significant disruptions in the pharmaceutical supply chain, affecting the production timelines and cost structures of drugs dependent on these materials.

2Supplier Concentration & Single-Source Risk

The export data for thalidomide from India indicates a high supplier concentration. The top five exporters account for 65.9% of the total export value, with BDR Pharmaceuticals International Private Limited alone contributing 24.2%. This concentration poses a single-source risk; any operational or regulatory issues faced by these key suppliers could significantly disrupt the supply chain.

Access Complete Thalidomide Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 822 transactions across 92 markets.

Request Demo View Pricing

Frequently Asked Questions — Thalidomide Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top thalidomide exporters from India?

The leading thalidomide exporters from India are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED, and 11 others. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED leads with 24.2% market share ($468.6K). The top 5 suppliers together control 65.9% of total export value.

What is the total export value of thalidomide from India?

The total export value of thalidomide from India is $1.9M, recorded across 822 shipments from 153 active exporters to 92 countries. The average shipment value is $2.4K.

Which countries import thalidomide from India?

India exports thalidomide to 92 countries. The top importing countries are ALGERIA (26.8%), SRI LANKA (14.5%), SERBIA (13.8%), VIETNAM (11.6%), SENEGAL (4.1%), which together account for 70.7% of total export value.

What is the HS code for thalidomide exports from India?

The primary HS code for thalidomide exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Thalidomide

Thalidomide

Top Thalidomide Exporters from India

Top Countries Importing Thalidomide from India

Who Supplies Thalidomide to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Thalidomide

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Thalidomide

Supply Chain Risk Assessment — Thalidomide

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Thalidomide Trade Intelligence

Frequently Asked Questions — Thalidomide Exports from India

Who are the top thalidomide exporters from India?

What is the total export value of thalidomide from India?

Which countries import thalidomide from India?

What is the HS code for thalidomide exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of thalidomide exports from India?

Which ports handle thalidomide exports from India?

Why is India a leading exporter of thalidomide?

What certifications do Indian thalidomide exporters need?

How many buyers import thalidomide from India?

What is the market share of the top thalidomide exporter from India?

Analysis Methodology